Nothing Special   »   [go: up one dir, main page]

BR0313182A - composições e produtos contendo equol enantiomérico - Google Patents

composições e produtos contendo equol enantiomérico

Info

Publication number
BR0313182A
BR0313182A BRPI0313182-3A BR0313182A BR0313182A BR 0313182 A BR0313182 A BR 0313182A BR 0313182 A BR0313182 A BR 0313182A BR 0313182 A BR0313182 A BR 0313182A
Authority
BR
Brazil
Prior art keywords
equol
products
compositions
disease
composition
Prior art date
Application number
BRPI0313182-3A
Other languages
English (en)
Inventor
Kenneth David Reginal Setchell
Sidney John Cole
Original Assignee
Childrens Hosp Medical Center
Australian Health & Nutrition
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30771209&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0313182(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Childrens Hosp Medical Center, Australian Health & Nutrition filed Critical Childrens Hosp Medical Center
Publication of BR0313182A publication Critical patent/BR0313182A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

COMPOSIçõES E PRODUTOS CONTENDO EQUOLENANTIOMéRICO. Uma composição para uso em preparação de alimento comercial e produtos de pele compreendendo S-equol, ou R-equol, ou misturas, incluindo igualmente uma mistura não-racêmica e uma mistura racêmica, de S-equol e R-equol. A composição pode ser usada para fazer artigos de comércio tal como suplementos de alimento, farmacêuticos, e medicamentos. As composições são úteis em um método de liberação de S-equol para um mamífero para prevenir ou tratar uma doença ou condição associada, inclusive doenças dependentes de hormónio ou condições tal como doença cardiovasclar, distúrbio de lipídio, osteopenia, osteoporose, doença de fígado, e deficiência de estrogênio ovariana aguda. O enantiómero de S-equol pode ser produzido em uma síntese biológica do metabolismo de uma isoflavona por um organismo.
BRPI0313182-3A 2002-07-24 2003-07-24 composições e produtos contendo equol enantiomérico BR0313182A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39827002P 2002-07-24 2002-07-24
PCT/US2003/023056 WO2004009035A2 (en) 2002-07-24 2003-07-24 Compositions and products containing enantiomeric equol, and methods for their making

Publications (1)

Publication Number Publication Date
BR0313182A true BR0313182A (pt) 2007-07-24

Family

ID=30771209

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0313182-3A BR0313182A (pt) 2002-07-24 2003-07-24 composições e produtos contendo equol enantiomérico

Country Status (8)

Country Link
US (8) US7396855B2 (pt)
EP (2) EP2526940A3 (pt)
JP (5) JP2006504409A (pt)
CN (3) CN101965974A (pt)
AU (1) AU2003259220C1 (pt)
BR (1) BR0313182A (pt)
CA (1) CA2492754C (pt)
WO (1) WO2004009035A2 (pt)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
WO2004039327A2 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
CA2492754C (en) 2002-07-24 2018-05-22 Children's Hospital Medical Center Compositions and products containing enantiomeric equol, and methods for their making
EP1542654A4 (en) * 2002-09-23 2008-12-17 Novogen Res Pty Ltd TREATMENT OF PHOTOTATIOOD AND ACTINIC DETERIORATION OF THE SKIN
US8580846B2 (en) * 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
DK1649760T3 (da) 2003-06-30 2013-07-08 Otsuka Pharma Co Ltd Sammensætning, som indeholder equol-producerende mælkesyrebakterie
JP2005232074A (ja) * 2004-02-19 2005-09-02 Tokyo Univ Of Agriculture 骨粗鬆症の予防及び／又は治療剤
CA2564399A1 (en) * 2004-04-28 2005-11-17 Brigham Young University Use of equol for treating skin diseases
US20090104167A1 (en) * 2005-07-29 2009-04-23 Calpis Co., Ltd. Prophylactic/Ameliorating Agent for Menopausal Disorder and Functional Beverage/Food
US7528267B2 (en) * 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
AU2006323754B2 (en) 2005-12-06 2011-12-15 Otsuka Pharmaceutical Co., Ltd. Equol-containing fermentation product of soybean embryonic axis, and method for production thereof
US20070166414A1 (en) * 2006-01-13 2007-07-19 Andreas Constantinou Method for enhancing tamoxifen efficacy as a cancer therapeutic
CA2640575C (en) * 2006-02-28 2016-05-17 Nestec S.A. Compositions and methods for inducing bone growth and inhibiting bone loss
JP5122766B2 (ja) * 2006-06-20 2013-01-16 ユニチカ株式会社 エコール産生促進組成物
US20080108696A1 (en) 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
JP2009545605A (ja) * 2006-08-02 2009-12-24 ユニバーシティ オブ サザン カリフォルニア フィトエストロゲン製剤およびその使用
US8680140B2 (en) 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
JP2010518164A (ja) * 2007-02-14 2010-05-27 マース インコーポレーテッド 神経性化合物
WO2008126752A1 (ja) 2007-04-09 2008-10-23 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo エクオール類を有効成分とする美白剤
AU2013203101B2 (en) * 2007-06-13 2015-07-09 Otsuka Pharmaceutical Co., Ltd. Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
MX2009013580A (es) * 2007-06-13 2010-01-20 Otsuka Pharma Co Ltd Extracto que contiene equol, metodo para la produccion del mismo, metodo para la extraccion de equol, y alimento que contiene equol.
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
EP2133080A1 (de) 2008-06-13 2009-12-16 Haelan Schweiz GmbH Zusammensetzungen enthaltend Equol
TWI637056B (zh) 2008-09-19 2018-10-01 大塚製藥股份有限公司 含有維持雌馬酚（ｅｑｕｏｌ）產生能力之產生雌馬酚之微生物的發酵製品及其製造方法（三）
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
EP2402429B1 (en) * 2009-02-25 2017-09-13 Kabushiki Kaisha Yakult Honsha Equol-producing bacterium and use thereof
CN102422160B (zh) * 2009-05-11 2014-09-10 荣研化学株式会社 利用免疫法测定生物样品中的雌马酚的方法、用于该测定的试剂盒、以及判定受试者的雌马酚产生能力的方法
US8257761B2 (en) * 2009-12-15 2012-09-04 Jacob Ludwig Manfred Polyphenol-containing products
US8372392B2 (en) * 2009-12-23 2013-02-12 Lytone Enterprise, Inc. Lactobacillus paracasei strain LT12 as immunity regulatory agent
JP5778701B2 (ja) 2010-03-01 2015-09-16 システム バイオロジー アーゲー エクオールの検出のための試験細片
CA2800838C (en) * 2010-05-28 2020-03-10 Nexgen Dermatologics, Inc. Combination therapy for skin disorders
US20130129651A1 (en) 2010-08-03 2013-05-23 Hayashibara Co., Ltd. Agent for enhancing the effect of skin-whitening ingredients and uses thereof
JP5731212B2 (ja) * 2011-01-31 2015-06-10 株式会社ダイセル イソフラボン発酵代謝産物の精製方法
JP2012176931A (ja) * 2011-01-31 2012-09-13 Angfa Co Ltd 育毛剤
CN102784135B (zh) * 2012-07-05 2014-11-05 西安交通大学 基于雌马酚激活BKCa通道的应用
US20160000747A1 (en) 2012-12-12 2016-01-07 Herrens Mark Aps Product comprising red clover extract and methods for producing the same
US20140178314A1 (en) 2012-12-19 2014-06-26 The Procter & Gamble Company Compositions and/or articles with improved solubility of a solid active
JP6132398B2 (ja) * 2013-06-04 2017-05-24 株式会社ダイセル エクオール以外のイソフラボン類の含有量が低いエクオール含有組成物
MY168984A (en) * 2013-10-06 2019-01-29 Fuji Oil Holdings Inc Oil or fat for tempering type chocolate
IN2013KO01293A (pt) * 2013-11-13 2015-05-15 Univ Calcutta
JP2015139424A (ja) * 2014-01-30 2015-08-03 株式会社ダイセル エクオール含有組成物の製造方法
WO2016061184A1 (en) 2014-10-14 2016-04-21 Jackson Richard L Anhydrous crystalline form of s-equol
JP2016196428A (ja) * 2015-04-03 2016-11-24 株式会社ダイセル エクオール及びキレート剤を含有する外用組成物
JP2016196430A (ja) * 2015-04-03 2016-11-24 株式会社ダイセル エクオール及び保湿剤を含有する外用組成物
JP6512548B2 (ja) * 2015-04-03 2019-05-15 株式会社ダイセル エクオール、酸化防止剤、及び油類を含有する外用組成物
EP3439651A4 (en) * 2016-04-06 2019-10-30 Noxopharm Limited IMPROVEMENTS IN CANCER TREATMENT
JP2019513826A (ja) 2016-04-06 2019-05-30 ノクソファーム リミティド 放射線療法の改善
US20190282540A1 (en) * 2016-04-06 2019-09-19 Noxopharm Limited Targeted drug delivery
JP2019513828A (ja) * 2016-04-06 2019-05-30 ノクソファーム リミティド 改善された薬物動態を有するイソフラボノイド組成物
CN106248816B (zh) * 2016-07-11 2018-10-19 山东省分析测试中心 拆分雌马酚对映异构体及测定其在豆制品中含量的方法
CN109862889A (zh) 2016-07-26 2019-06-07 奥西制药有限公司 用s-雌马酚诊断和治疗阿尔茨海默病的方法
JP6586604B2 (ja) * 2016-07-27 2019-10-09 株式会社ヘルスケアシステムズ 骨折リスク評価方法
CN111465327A (zh) * 2017-07-24 2020-07-28 北卡罗莱纳州立大学 用于提高植物化学物质生物利用度和生物活性的组合物和方法
CN108576807A (zh) * 2018-04-04 2018-09-28 江瀚生物科技（上海）有限公司 一种有效提高老年人群钙质吸收率的小分子营养素及其制备方法
AU2019285640A1 (en) * 2018-06-15 2021-01-21 Board Of Regents Of The University Of Texas System Methods of treating and preventing breast cancer with S-equol
AU2019285641A1 (en) 2018-06-15 2021-04-08 The Board Of Regents Of The University Of Texas System Methods of treating and preventing melanoma with s-equol
JP2022022349A (ja) * 2018-10-24 2022-02-03 株式会社ダイセル エクオール含有組成物の製造方法
JP2019011370A (ja) * 2018-10-24 2019-01-24 株式会社ダイセル エクオール含有組成物の製造方法
US20210222206A1 (en) * 2020-01-21 2021-07-22 Daicel Corporation Method for producing functional substance
AU2021247415A1 (en) 2020-03-30 2022-09-29 Noxopharm Limited Methods for the treatment of inflammation associated with infection
JPWO2022050308A1 (pt) * 2020-09-04 2022-03-10
JP2022132404A (ja) * 2021-12-07 2022-09-08 株式会社ダイセル エクオール含有組成物の製造方法
JP2023105251A (ja) * 2022-07-13 2023-07-28 株式会社ダイセル エクオール含有組成物の製造方法
JP7286861B1 (ja) 2022-11-16 2023-06-05 三和酒類株式会社 Ｇａｂａを有効成分とする乳腺組織の健康維持剤

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390559A (en) * 1979-04-11 1983-06-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
USRE34457E (en) 1983-12-28 1993-11-30 Daicel Chemical Industries, Inc. Separating agent
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
JPH02124883A (ja) 1988-11-04 1990-05-14 Kitasato Inst:The 抗酸化作用を有するイソフラボン誘導体およびその製造法
CH679584A5 (pt) * 1989-11-10 1992-03-13 Nestle Sa
DK0656786T3 (da) * 1992-05-19 2004-11-08 Novogen Res Pty Ltd Anvendelse af isoflavonphytoöstrogenekstrakter af soja eller klöver
WO1994023716A1 (en) * 1993-04-16 1994-10-27 Tufts University School Of Medicine Method for treatment of menopausal and premenstrual symptoms
US5320949A (en) * 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
US5424331A (en) * 1994-06-10 1995-06-13 Bio-Virus Research Incorporated Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
WO1996010341A1 (en) 1994-10-03 1996-04-11 Schouten Industries B.V. Food and health products
US5523087A (en) * 1995-02-15 1996-06-04 Bio-Virus Research Incorporated Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
FR2731706B1 (fr) * 1995-03-14 1997-04-11 Cird Galderma Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US5554519A (en) 1995-08-07 1996-09-10 Fermalogic, Inc. Process of preparing genistein
US6261565B1 (en) 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5821361A (en) * 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
AU6617196A (en) 1996-07-12 1998-02-09 Michel Gontier Soil disinfecting equipment
AUPO203996A0 (en) 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US5726034A (en) * 1996-09-06 1998-03-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
US6020471A (en) * 1996-09-13 2000-02-01 Abbott Laboratories Process for isolating phytoestrogens from plant protein
US5804234A (en) * 1996-09-13 1998-09-08 Suh; John D. Plant protein for nutritional products and method of making same
AU5260698A (en) * 1996-11-18 1998-06-10 Internutria, Inc. Composition and treatment for persistent reproductive transition symptoms
US5733926A (en) 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
AUPO427196A0 (en) 1996-12-19 1997-01-23 University Of Sydney, The A method for preventing or controlling cataract
WO1998048790A1 (en) 1997-04-28 1998-11-05 Anticancer, Inc. Use of genistein and related compounds to treat certain sex hormone related conditions
US6146668A (en) * 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
JP2001523258A (ja) * 1997-05-01 2001-11-20 ノボゲン インコーポレイテッド 更年期症状および骨粗鬆症の治療または予防
US6083526A (en) * 1997-05-22 2000-07-04 Gorbach; Sherwood L. Use of isoflavonoids in the treatment or prevention of postpartum depression
US6060070A (en) * 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
EP1025850B1 (en) * 1997-08-08 2005-11-23 Otsuka Pharmaceutical Co., Ltd. Isoflavone-containing compositions
US6521433B1 (en) * 1997-09-17 2003-02-18 E. I. Du Pont De Nemours And Company cDNA sequences from plants that encode activities associated with isoflavone biosynthesis
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US5952374A (en) * 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
US5942539A (en) * 1997-10-03 1999-08-24 Wake Forest University Methods of treating or preventing endometriosis with phytoestrogens
AUPP112497A0 (en) 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
US5958946A (en) * 1998-01-20 1999-09-28 Styczynski; Peter Modulation of hair growth
US6004558A (en) * 1998-02-25 1999-12-21 Novogen, Inc. Methods for treating cancer with legume plant extracts
DE69925658T2 (de) 1998-03-12 2005-11-10 Mitsubishi Gas Chemical Co., Inc. Sauerstoffabsorbierende Mehrschichtfolie, deren Herstellungsverfahren und Verpackungsbehälter
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
US6086915A (en) 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
PE20000559A1 (es) 1998-05-27 2000-07-05 Merck & Co Inc Formulacion de tabletas comprimidas de efavirenz
EP1082122A4 (en) 1998-05-27 2003-04-09 Sherwood L Gorbach ISOFLAVONOIDS USEFUL IN THE TREATMENT AND PREVENTION OF MIGRAINE HEADACHE
BR9906998A (pt) 1998-09-10 2000-09-26 Avon Prod Inc Método e composições para reduzir o envelhecimento dermatológico e para reduzir contusões
CA2352338A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases
BR9915693A (pt) 1998-11-25 2001-08-14 Nutri Pharma As Composição compreendendo proteìna de soja, fibra de dieta e um composto fitoestrogênio e seu uso na prevenção e/ou tratamento de diabetes tipo 2, a sìdrome metabólica e doenças cardiovasculares associadas
AU767245B2 (en) * 1998-11-25 2003-11-06 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
AU1995400A (en) 1999-01-15 2000-08-01 Nutrahealth Ltd (Uk) Modified food products and beverages, and additives for food and beverages
AUPP868599A0 (en) 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
EP1077498A1 (en) 1999-03-04 2001-02-21 Japan Storage Battery Co., Ltd. Composite active material and method for preparing active material, electrode and method for preparing electrode, and non-aqueous electrolyte cell
CZ20013714A3 (cs) * 1999-04-16 2002-08-14 Astrazeneca Ab Léčivo pro léčení nemocí spojených s receptorem - beta estrogenu
US6592910B1 (en) 1999-04-20 2003-07-15 Board Of Trustees, Southern Illinois University Methods of treating clinical diseases with isoflavones
US6544566B1 (en) * 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US6159959A (en) * 1999-05-06 2000-12-12 American Home Products Corporation Combined estrogen and antiestrogen therapy
US6375994B1 (en) * 1999-08-20 2002-04-23 Sun Ten Laboratories, Inc. Preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability
US6159935A (en) 1999-11-29 2000-12-12 Pharmacia & Upjohn Co. Method for preventing diarrhea
CA2416796A1 (en) * 2000-06-14 2001-12-20 Alla Shapiro Radioprotective agents
WO2002003992A2 (en) 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating prosthesis-related bone degeneration
JP2004502731A (ja) 2000-07-06 2004-01-29 ワイス スタチン、エストロゲン剤および所望によるエストロゲンの組み合わせ
US6455568B2 (en) * 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
AU2001273125A1 (en) 2000-07-06 2002-01-21 American Home Products Corporation Combinations of bisphosphonates, estrogenic agents and optionally estrogens
AU2001283322A1 (en) 2000-08-10 2002-02-18 M. D. Brian D. Zelickson Organic nutrient for hair loss treatment
US6326366B1 (en) * 2000-08-22 2001-12-04 Protein Technologies International Hormone replacement therapy
US6565864B2 (en) * 2000-12-28 2003-05-20 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Skin care product containing retinoids and phytoestrogens in a dual compartment package
US20020143059A1 (en) 2000-12-28 2002-10-03 Sreekumar Pillai Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package
US20020192310A1 (en) 2001-02-02 2002-12-19 Bland Jeffrey S. Medical composition for managing hormone balance
JP3846775B2 (ja) 2001-02-06 2006-11-15 新キャタピラー三菱株式会社 作業機械におけるブームシリンダの油圧制御回路
EP1234572B1 (de) * 2001-02-26 2013-10-30 Mibelle AG Cosmetics Isoflavon-Aglykone enhaltende Hautbehandlungsmittel
EP1370294A2 (en) 2001-02-27 2003-12-17 The Regents Of The University Of Michigan Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor
DE10121375B4 (de) 2001-05-02 2014-01-16 Beiersdorf Ag Verwendung von Isoflavonoiden in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut
DE10122342A1 (de) 2001-05-09 2002-11-14 Beiersdorf Ag Verwendung von Isoflavonen in kosmetischen oder dermatologischen Zubereitungen
FR2825277B1 (fr) * 2001-05-30 2004-10-15 Oreal Composition cosmetique et/ou dermatologique et/ou pharmaceutique contenant au moins un compose ihnibiteur de l'enzime 3, b-hsd
US6597597B2 (en) * 2001-11-13 2003-07-22 Hewlett-Packard Company Low temperature attaching process for MRAM components
CA2492754C (en) * 2002-07-24 2018-05-22 Children's Hospital Medical Center Compositions and products containing enantiomeric equol, and methods for their making
WO2004039327A2 (en) * 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
AU2002951271A0 (en) 2002-09-06 2002-09-19 Novogen Research Pty Ltd Repair of dna mutagenic damage
EP1542654A4 (en) 2002-09-23 2008-12-17 Novogen Res Pty Ltd TREATMENT OF PHOTOTATIOOD AND ACTINIC DETERIORATION OF THE SKIN
US8580846B2 (en) * 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
US7025998B2 (en) * 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
US8680140B2 (en) 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
US20080108696A1 (en) 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
US7985161B2 (en) * 2007-06-07 2011-07-26 GM Global Technology Operations LLC Multi-speed transmission
US7960753B2 (en) * 2007-09-11 2011-06-14 The Aerospace Corporation Surface plasmon polariton actuated transistors

Also Published As

Publication number Publication date
CA2492754A1 (en) 2004-01-29
JP2006504409A (ja) 2006-02-09
US8048913B2 (en) 2011-11-01
JP2016041693A (ja) 2016-03-31
US20120004189A1 (en) 2012-01-05
CN1681386B (zh) 2010-05-26
US9018247B2 (en) 2015-04-28
EP1545206B1 (en) 2020-03-04
AU2003259220B2 (en) 2009-01-08
AU2003259220A1 (en) 2004-02-09
US9408824B2 (en) 2016-08-09
US20120122967A2 (en) 2012-05-17
CN101965974A (zh) 2011-02-09
EP1545206A4 (en) 2006-10-04
CN1681386A (zh) 2005-10-12
US20090018185A1 (en) 2009-01-15
US20100120705A1 (en) 2010-05-13
EP1545206A2 (en) 2005-06-29
CA2492754C (en) 2018-05-22
JP2016053027A (ja) 2016-04-14
AU2003259220C1 (en) 2017-08-24
EP2526940A3 (en) 2014-07-30
US9173866B2 (en) 2015-11-03
US20040235758A1 (en) 2004-11-25
US20150038570A1 (en) 2015-02-05
US7396855B2 (en) 2008-07-08
US20040147594A1 (en) 2004-07-29
CN104643057A (zh) 2015-05-27
EP2526940A2 (en) 2012-11-28
US20120040921A1 (en) 2012-02-16
US7960432B2 (en) 2011-06-14
WO2004009035A3 (en) 2004-11-04
US20140039046A1 (en) 2014-02-06
JP2010143930A (ja) 2010-07-01
WO2004009035A2 (en) 2004-01-29
JP2013253096A (ja) 2013-12-19

Similar Documents

Publication Publication Date Title
BR0313182A (pt) composições e produtos contendo equol enantiomérico
AU2006305808B2 (en) Compositions and methods for increasing lean muscle mass and/or reducing fat gain
BRPI0508879A (pt) transferência de ingredientes funcionais
BRPI0517500A (pt) compostos, uso de uma composição, composição farmacêutica, composição cosmética, uso não-terapêutico de uma composição cosmética e processo cosmético para melhorar a aparência da pele
Wallace et al. Dietary bioactives: establishing a scientific framework for recommended intakes
EP2114925B8 (en) Azetidine analogues of nucleosidase and phosphorylase inhibitors
Cashman The role of vitamers and dietary-based metabolites of vitamin D in prevention of vitamin D deficiency
HUP0200190A3 (en) Dimeric compounds and as inhibitors of neuraminidase, process for their preparation and pharmaceutical compositions containing them
MXPA04009765A (es) Metodo para mejorar la absorcion de la vitamina e por una mascota animal.
DE60308810D1 (de) Anregung der in-vivo synthese von proteinen mit zusammensetzungen enthaltend leucin
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
CN1429105A (zh) 含有作为活性成分的辅酶q的皮肤组合物
BRPI0511047A (pt) processos para a preparação de extratos vegetais e composições alimentìcias para animais de estimação
MXPA05005171A (es) Compuestos bi-aromaticos activadores de los receptores de tipo ppar-gama y su uso en composiciones cosmeticas o farmaceuticas.
DE50000508D1 (de) Traubenkerne, kaltgepresstes traubenkernöl, traubenkernschrot und traubenkernmehl
BRPI0514448A (pt) derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias
DE602006011127D1 (de) Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
BRPI0411503A (pt) composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto
ATE435864T1 (de) Substituierte 5,6,7,8-tetrahydro-imidazoä1 ,2- aüpyridin-2-ylamin-verbindungen und deren verwendung zur herstellung von arzneimitteln
NO20084478L (no) Konjugerte lipidderivater
EP2168442A3 (de) Geranylaminderivate der Oxalsäure
BRPI0507435A (pt) compostos de piperidinilcarbonilpirrolidinas, processos para a preparação do mesmo,composição farmacêutica e uso como agonistas de melanocortina
BR0317452A (pt) Métodos para revestimento de substratos para usos farmacêuticos com uma mistura de dois agentes de revestimento formadores de pelìculas
BRPI0410623A (pt) composto, processo para preparação de um composto, composição farmacêutica, e, utilização de um composto
BR0312318A (pt) Compostos, uso de um ou mais compostos, composição farmacêutica, composição cosmética e usos cosméticos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL